Videos

AJ interview.PNG

Silence Therapeutics' (LON:SLN) Executive Chair, Annalisa Jenkins sat down with Proactive's Andrew Scott to discuss her strategy for taking the drug developer forward and the 'exciting opportunities' in the RNAi space.